Method for manufacturing a recombinant polyclonal protein

Details for Australian Patent Application No. 2008255383 (hide)

Owner Symphogen A/S

Inventors Nielsen, Lars Soegaard; Tolstrup, Anne Bondgaard; Muller, Christian; Weilguny, Dietmar; Wiberg, Finn

Agent Spruson & Ferguson

Pub. Number AU-B-2008255383

PCT Pub. Number WO2008/145133

Priority PA 2007 00764 25.05.07 DK; PA 2007 01292 07.09.07 DK; 60/960,002 11.09.07 US; 60/924,708 29.05.07 US

Filing date 21 May 2008

Wipo publication date 4 December 2008

Acceptance publication date 1 November 2012

International Classifications

C07K 16/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/10 Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

Event Publications

10 December 2009 PCT application entered the National Phase

  PCT publication WO2008/145133 Priority application(s): WO2008/145133

1 November 2012 Application Accepted

  Published as AU-B-2008255383

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008255387-Recombinant non glycosylated monovalent half-antibodies obtained by molecular engineering

2008255382-Secure login protocol